[Randomized phase II study of carboplatin/paclitaxel followed by gemcitabine versus carboplatin/gemcitabine followed by docetaxel in patients with advanced nonsmall cell lung cancer].

Source:http://linkedlifedata.com/resource/pubmed/id/18633251

Download in:

View as

General Info

PMID
18633251